ImQuest understands that one of the greatest challenges faced by a company is obtaining the necessary financial, technical and professional resources required to successfully submit an Investigational New Drug application to the Food and Drug Administration. ImQuest is prepared to assist our clients in various ways to traverse the drug development “Valley of Death” such that highly novel, potent and effective products have the opportunity to enter human clinical trials. This value added service offering by ImQuest may take many forms, from fee-for-service to direct drug development partnerships based on due diligence performed by ImQuest scientific staff. Proposals for Drug Development Partnerships with ImQuest should be submitted to our Chief Executive Officer, Robert Buckheit, at rbuckheit@imquestbio.com.